Details

Autor(en) / Beteiligte

• Dhondup, Yangchen, MD
• Ueland, Thor, PhD
• Dahl, Christen Peder, MD, PhD
• Askevold, Erik Tandberg, MD, PhD
• Sandanger, Øystein, MD, PhD
• Fiane, Arnt, MD, PhD
• Ohm, Ingrid Kristine, PhD
• Sjaastad, Ivar, MD, PhD
• Finsen, Alexandra Vanessa, MD, PhD
• Wæhre, Anne, MD, PhD
• Gullestad, Lars, MD, PhD
• Aukrust, Pål, MD, PhD
• Yndestad, Arne, MScPharm, PhD
• Vinge, Leif Erik, MD, PhD

Titel

Low Circulating Levels of Mitochondrial and High Levels of Nuclear DNA Predict Mortality in Chronic Heart Failure

Ist Teil von

• Journal of cardiac failure, 2016-10, Vol.22 (10), p.823-828

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2016

Quelle

Elsevier ScienceDirect Journals

Beschreibungen/Notizen

• Abstract Background Mitochondrial DNA (mtDNA) and possibly nuclear DNA (nDNA) are released as danger-associated molecular patterns during cardiac stress, and may activate several innate immune receptors. The purpose of this study was to investigate the regulation of these danger-associated molecular patterns during human heart failure (HF). Methods and Results Plasma levels of mtDNA and nDNA from HF patients (n = 84) were analyzed by reverse transcriptase-polymerase chain reaction and compared with controls (n = 72). Increased levels of mtDNA were found in New York Heart Association (NYHA) I-II and NYHA III-IV. There was evidence of increased nDNA in NYHA III-IV compared with controls and NYHA I-II. Kaplan-Meier analysis revealed higher mortality in patients with high nDNA levels, whereas high levels of mtDNA were associated with survival. Conclusions Plasma levels of mtDNA and nDNA are elevated in human HF associated with increased and decreased mortality, respectively. This study may suggest a rationale for exploring interventions within inflammatory signaling pathways activated by nucleic acids as novel targets in treatment of HF.